Orum Therapeutics IPO Preview

• Orum Therapeutics is getting ready to complete its IPO in KOSDAQ in November 2024. The IPO price range is from 30,000 won to 36,000 won.

• The expected market cap after IPO is from 648 billion won to 778 billion won. The book building for the institutional investors starts on 24 October.

• Orum Therapeutics' main pipelines include 'ORM-6151', a new drug candidate for acute myeloid leukemia, 'ORM-5029', a HER2-targeting breast cancer treatment candidate, and 'ORM-1023', a small cell carcinoma tumor candidate.